Device closure of atrial septal defect: medium-term outcome with special reference to complications

Masood Sadiq1, Tehmina Kazmi, Asif U Rehman

  • 1Department of Paediatric Cardiology, The Children's Hospital, Ferozepur Road, Lahore, Pakistan. drmasoodsadiq@hotmail.com

Insights

Device closure for secundum atrial septal defects is safe and effective long-term. Key complications like embolisation and residual shunts are linked to specific anatomical factors, while aortic regurgitation risk remains low.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Concerns exist regarding device closure of secundum atrial septal defects (ASD), particularly regarding erosions and aortic regurgitation.
  • Transcatheter device closure has become a common alternative to surgical repair for ASD.

Purpose of the Study:

  • To evaluate the medium-term outcomes of transcatheter device closure for secundum ASD.
  • To specifically assess the incidence of complications such as erosions and aortic regurgitation.

Main Methods:

  • 205 patients with secundum ASD underwent transcatheter closure using the Amplatzer Septal Occluder between 1999 and 2009.
  • Medium-term follow-up data was available for 176 patients (88%).

Main Results:

  • Successful device closure was achieved in 98% of patients.
  • Complications included device embolisation (associated with short inferior caval vein margin), residual shunts (associated with short superior caval vein margin), and mild aortic regurgitation (linked to a high device-to-defect ratio).
  • No erosions, late embolisation, or thromboembolism were observed.

Conclusions:

  • Transcatheter device closure of secundum ASD with the Amplatzer device is safe and effective in the medium term.
  • Specific anatomical features predict risks of embolisation and residual shunts.
  • The risk of aortic regurgitation is low and predictable based on device selection.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...